...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: $1.73 and $1.75.....

The 20 and 50 day moving averages are at $1.73 and the 200 is at $1.75......the technical picture will start turning bullish when we get above those levels.

New Message
Please login to post a reply